Winfried Haerer

The Changing Landscape for Stroke Prevention in AF

Menno V. Huisman, Kenneth J. Rothman, Miney Paquette et al. · Journal of the American College of Cardiology · 2017 · 281 citations · Full text

Medicine, Cardiology, Pharmacotherapy +10

Intravenous Recombinant Tissue Plasminogen Activator (rt-PA) and Urokinase in Acute Myocardial Infarction: Results of the German Activator Urokinase Study (GAUS)

Karl-Ludwig Neuhaus, Ulrich Tebbe, Martin Gottwik et al. · Journal of the American College of Cardiology · 1988 · 214 citations

Medicine, Cardiology, Internal Medicine +16

Pharmacokinetics and Haemostatic Status During Consecutive Infusions of Recom binant Tissue-Type Plasminogen Activator in Patients with Acute Myocardial Infarction

Erhard Seifried, P. Tanswell, D. Ellbrück et al. · Thrombosis and Haemostasis · 1989 · 75 citations

Medicine, Pharmacokinetics, Pharmacology +16

Relationships between <scp>HMG‐CoA</scp> reductase inhibitors (statin) use and strength, balance and falls in older people

Winfried Haerer, Kim Delbaere, Harry Bartlett et al. · Internal Medicine Journal · 2011 · 32 citations · Full text

Medicine, Geriatric Medicine, Pharmacotherapy +17

Acute and chronic effects of a diuretic monotherapy with piretanide in congestive heart failure—A placebo-controlled trial

Winfried Haerer, Ulrike Bauer, N. Sultan et al. · Cardiovascular Drugs and Therapy · 1990 · 27 citations

Pharmacy, Cardiology, Pharmacotherapy +14